The first full week of the Wall Street earnings season for Q3 2023 has just begun. The schedule is still dominated by financial institutions, as it was the case in the previous week, but earnings stream will get much more diverse this week.
5 Dow Jones members will report this week - Johnson & Johnson (JNJ.US), Goldman Sachs (GS.US), Procter & Gamble (PG.US), Travelers (TRV.US) and American Express (AXP.US) - representing around 18% of index weight. On top of that, investors will be offered reports from other such well-known companies like Tesla (TSLA.US) or Netflix (NFLX.US).
Schedule of this week's top US earnings reports can be found below.
Top Wall Street earnings reports this week. Source: Bloomberg, XTB Research
Rheinmetall earninigs: Weak sales overshadow strong prospects
ARM Holdings Moves Closer to the Center of the AI Revolution. Strong Results Are No Longer Enough for the Market
Market wrap 🚨Oil slips below $100 supporting optimism across European and US stocks
US Open: Wall Street climbs higher driven by oil sell-off and technology stocks optimism 📈
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.